BIOMAT Database Logo BIOMAT Database Logo

[Apomorphine treatment of withdrawal symptoms in young opiate addicts]. 1976

N C Gulmann, and B Kaldan, and F Kobbernagal

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D009021 Morphine Dependence Strong dependence, both physiological and emotional, upon morphine. Morphine Abuse,Morphine Addiction,Abuse, Morphine,Addiction, Morphine,Dependence, Morphine
D009892 Opium The air-dried exudate from the unripe seed capsule of the opium poppy, Papaver somniferum, or its variant, P. album. It contains a number of alkaloids, but only a few - MORPHINE; CODEINE; and PAPAVERINE - have clinical significance. Opium has been used as an analgesic, antitussive, antidiarrheal, and antispasmodic. Omnopon,Papaveretum,Pantopon
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001058 Apomorphine A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

N C Gulmann, and B Kaldan, and F Kobbernagal
[Apomorphine in opiate withdrawal treatment].
April 1972, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
N C Gulmann, and B Kaldan, and F Kobbernagal
Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment.
January 1989, Journal of psychiatric research,
N C Gulmann, and B Kaldan, and F Kobbernagal
Treatment of opiate-withdrawal symptoms.
August 1980, Lancet (London, England),
N C Gulmann, and B Kaldan, and F Kobbernagal
[Withdrawal and management of opiate addicts].
June 1995, La Revue du praticien,
N C Gulmann, and B Kaldan, and F Kobbernagal
Early treatment time course of depressive symptoms in opiate addicts.
April 1991, The Journal of nervous and mental disease,
N C Gulmann, and B Kaldan, and F Kobbernagal
Double blind assessment of buprenorphine withdrawal in opiate-addicts.
January 1990, NIDA research monograph,
N C Gulmann, and B Kaldan, and F Kobbernagal
Double-blind assessment of buprenorphine withdrawal in opiate-addicts.
January 1990, NIDA research monograph,
N C Gulmann, and B Kaldan, and F Kobbernagal
Withdrawal symptoms in cannabis indica addicts.
October 1949, Lancet (London, England),
N C Gulmann, and B Kaldan, and F Kobbernagal
Blockade of acute opiate-withdrawal symptoms by trazodone treatment.
July 1979, Bollettino chimico farmaceutico,
N C Gulmann, and B Kaldan, and F Kobbernagal
[Withdrawal in opiate addicts in an internal medicine hospital unit].
October 1995, Bulletin de l'Academie nationale de medecine,
Copied contents to your clipboard!